Loading
CH
Chr. Hansen Holding: what insiders have been doing
Only a handful of insider records exist for Chr. Hansen Holding, the last one from 24 November 2005, too few to describe a trend. Every figure here comes from the filings published by Finanstilsynet DK and describes the past, not future prices; it is not investment advice.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
n/a
Fundamental score
Ranked 1,597 of 24,148 companies
77.1
score / 100
Value84
Quality70
FCF yld18%
Earn yld5.8%
EV/EBITDA4.4x
ROE17%
Gross mgn66%
Net mgn5.6%
Debt/EBITDA1.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2025FY ended December 2025 · cache
€432.20
Analyst consensus
Income statement
Revenue€80.8B
Gross profit€53.5B66% margin
EBITDA€25.9B32% margin
Net income€4.5B5.7% margin
Valuation
PER (trailing)17.1x
P/Book3.2x
Beta0.86
Balance sheet & cash
Market cap€78.0B
Total debt€36.7B
Free Cash Flow€14.2B
Debt / Equity55%
Profitability & ownership
ROE17.1%
ROA7.6%
% insiders97.5%
% institutions0.4%
Last declaration on 24 November 2005
About Chr. Hansen Holding
Chr. Hansen Holding is a Danish company specializing in the distribution and commerce of microbial cultures and natural ingredients. It provides solutions for the food, beverage, nutraceutical, and pharmaceutical industries.
